PsychU

The Agitation In Alzheimer's Screener For Caregivers (AASC™) - A New Tool To Disease Recognition
2023-11-29 12:00 - 13:00 (America/New_York)
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Agitation is one of the most common neuropsychiatric symptoms of Alzheimer’s dementia, and one of the most complex, prominent, stressful, and costly aspects of care.1 Caregivers are often first to encounter agitation-associated behaviors and play a pivotal role in communicating these symptoms to healthcare providers (HCPs).2,3 Agitation associated with Alzheimer’s dementia (AAD) causes a significant clinical, humanistic, and economic burden on community, family, and professional caregivers.4,5,6,7 AAD is notably underdiagnosed, and most caregivers do not identify the breadth of signs/symptoms of agitation and are hesitant to discuss these behaviors with HCPs.8 Therefore, there’s a need for an easy, pragmatic screener to facilitate caregiver recognition of AAD and HCP discussions. AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders,9 was designed to assist caregivers in recognizing AAD. Dr. Carolyn Clevenger will discuss development of the AASC™ tool and its potential to improve communication between caregivers and providers, and ultimately recognition of agitation behaviors.
References:

Halpern R, et al. Int J Geriatr Psychiatry. 2019;34(3):420-431
Lindeza P, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242
Gallego-Alberto L, et al. Clin Gerontol. 2022;45(5):1295-1303
Fillit H, et al. Int J Geriatr Psychiatry. 2021 ;36(12) :1959-1969
Jones E, et al. J Alzheimers Dis. 2021 ;83(1) :89-101
Schein J, et al. J Alzheimers Dis. 2022 ;88(2) :663-677
Palm R, et al. J Alzheimers Dis. 2018 ;66(4) :1463-1470
Lanctot KL, et al. Alzheimers Dement (NY). 2017 ;3(3) :440-449
Sano M, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041

Featuring

Carolyn Clevenger, DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA
Professor of Transformative Clinical Practice, Emory University School of Nursing, Clinical Director and Gerontological Nurse Practitioner at Integrated Memory Care Clinic

More

Carolyn Clevenger DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA, is Professor of Transformative Clinical Practice at the Emory University School of Nursing in Atlanta, Georgia. She serves as Clinical Director and Gerontological Nurse Practitioner at Emory’s Integrated Memory Care Clinic, a patient-centered medical home providing integrated memory care and primary care for persons living with dementia. She is a Past President of the Gerontological Advanced Practice Nurses Association, and Fellow of the American Association of Nurse Practitioners (AANP) and the Gerontological Society of America.

Mike Crooks, PharmD, BCGP
Senior Long-Term Care Medical Science Liaison

Speaker Carolyn Clevenger DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Moderator Mike Crooks, Pharm D, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Home

Events

Webinar

Conversations Matter: The Importance Of Effective Communication Between Healthcare Providers & Care Partners Of Individuals Living With Agitation In Alzheimer's Dementia (AAD)
2023-12-13 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers (HCPs)2,3. Early identification, management and treatment of AAD has been shown to improve patient outcomes and reduce caregiver burden4,5, highlighting the importance of a strong therapeutic alliance between care partners and HCPs. In this webinar, geriatric psychiatrist, Dr. Marc Agronin, and care partner, Carrie Shaw, share their unique but complimentary perspectives on identifying and responding to agitation and navigating the shared decision-making process. Our speakers will discuss best practices for how to effectively prepare for and communicate during an appointment and what tools and resources are available for care partners. One such tool they review is the AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders6, which was designed to assist caregivers in recognizing AAD.

Click here to register for the 3:00 pm EST broadcast

References:

Stella F, et al. Int J Geriatr Psychiatry. 2015;30(12):1230-1237
Lindeza P, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242.
Gallego-Alberto L, et al. Clin Gerontol. 2022;45(5):1295-1303.
Hoe J, et al. BJPsych Open. 2017;3(1):34-40.
Janzen S, et al. Am J Alzheimers Dis Other Demen. 2013;28(5):524-532
Sano M, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041

Featuring

Marc E. Agronin, MD
Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine

Carrie Shaw, MD
CEO & Founder of Embodied Labs

Miranda Fisher, PhD
Medical Science Liaison

Marc Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Miranda Fisher, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Conversations Matter: The Importance Of Effective Communication Between Healthcare Providers & Care Partners Of Individuals Living With Agitation In Alzheimer’s Dementia (AAD)
2023-12-13 15:00 - 16:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers (HCPs)2,3. Early identification, management and treatment of AAD has been shown to improve patient outcomes and reduce caregiver burden4,5, highlighting the importance of a strong therapeutic alliance between care partners and HCPs. In this webinar, geriatric psychiatrist, Dr. Marc Agronin, and care partner, Carrie Shaw, share their unique but complimentary perspectives on identifying and responding to agitation and navigating the shared decision-making process. Our speakers will discuss best practices for how to effectively prepare for and communicate during an appointment and what tools and resources are available for care partners. One such tool they review is the AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders6, which was designed to assist caregivers in recognizing AAD.

Click here to register for the 12:00 pm EST broadcast

References:

Stella F, et al. Int J Geriatr Psychiatry. 2015;30(12):1230-1237
Lindeza P, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242.
Gallego-Alberto L, et al. Clin Gerontol. 2022;45(5):1295-1303.
Hoe J, et al. BJPsych Open. 2017;3(1):34-40.
Janzen S, et al. Am J Alzheimers Dis Other Demen. 2013;28(5):524-532
Sano M, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041

Featuring

Marc E. Agronin, MD
Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine

Carrie Shaw, MD
CEO & Founder of Embodied Labs

Miranda Fisher, PhD
Medical Science Liaison

Marc Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Miranda Fisher, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Let’s Face It, The Current Treatment Options For MDD Are Not Enough: Learn About Cognitive Emotional Training
2024-02-22 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
During an expert interview, Otsuka Sr. MSL, Dr. Mark Tacelosky will be talking with Dr. Brian Iacoviello who will guide us through Cognitive Emotional Training for the treatment of major depressive disorder (MDD). The objectives of this activity include providing the rationale for the role of cognitive-emotional training, exploring the steps for developing a cognitive-emotional training intervention for the treatment of MDD, reviewing the options for the digital delivery of cognitive emotional training, and discussing the possibilities for future research and applications.

Featuring

Brian Iacoviello, PhD
Assistant Professor, Icahn School of Medicine at Mount Sinai New York, NY

More

Dr. Iacoviello is a clinical psychologist and assistant professor at the Icahn School of Medicine at Mount Sinai. He earned his Masters and PhD in clinical psychology from Temple University in PA. Dr Iacoviello specializes in treating mood and anxiety disorders, using cognitive behavioral therapy, dialectical behavior therapy, acceptance and commitment therapy and motivational interviewing. His research delves into understanding fundamental cognitive behavioral patterns associated with depression, bipolar disorder, and anxiety disorders to search for novel treatments

Mark Tacelosky, PharmD
Senior Medical Science Liaison

Brian Iacoviello, PhD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Mark Tacelosky, PharmD is an employee for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs
2024-02-28 12:00 - 12:30
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Current evidence-based guidelines for the diagnosis and treatment of post-traumatic stress disorder (PTSD) are valuable resources and can be used to help develop individual treatment plans for patients. This webinar will examine the current PTSD treatment landscape, including discussions on both psychotherapy and pharmacotherapy. In addition, presenters will review limitations and key considerations in the treatment of PTSD.

Featuring

David Block, MD, MMM, FAPA
Clinical Assistant Professor of Psychiatry, Western University of Health Sciences, Loma Linda University and California University of Health and Medicine; Private Practitioner, Costa Mesa, CA

More

Dr. David Block, a psychiatrist in Orange County, CA, is dual board-certified in psychiatry and addiction medicine and was elected to become a Fellow of the American Psychiatric Association in January 2014. Currently, he is the Clinical Assistant Professor of Psychiatry at the Western University of Health Sciences, Loma Linda University and California University of Health and Medicine, and is a Private Practitioner in Costa Mesa, CA.

Dr. Block has worked extensively in college mental health, managed health care, and community treatment settings with severely and persistently mentally ill individuals. He has extensive clinical experience working with individuals with PTSD, from both his public and private sector work, Additionally, he has written several articles in the psychiatric literature and taught seminars and lectures to students training in the mental health professions.

Madeline Shurtleff, PharmD
Managed Market Liaison

More

Dr. Shurtleff is a clinical pharmacist with experience in managed care and retail pharmacy. She has extensive knowledge in Medicaid and Medicare pharmacy operations and regulatory requirements. Dr. Shurtleff received her Doctor of Pharmacy (PharmD), Business Minor, and Leadership Minor from the University of Rhode Island. She is a licensed pharmacist in Illinois and Arizona.

David Block, MD, MMM, FAPA is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.Madeline Shurtleff, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Comorbidities In Patients Living With Bipolar I Disorder
2024-03-28 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Lifetime comorbidity rates in bipolar disorder are ~90%, and nearly half of these patients are treated for a minimum of three1. During this webinar, Otsuka Sr. MSL Dr. Michael Aldape will be talking with Dr. Joseph Goldberg who will guide us on a lively discussion addressing the complexities of psychiatric comorbidities associated with bipolar I disorder. This moderated session will explore common comorbidities, treatment options and the current guidelines for managing comorbid bipolar I patients.

1. Altinbas, K. Treatment of Comorbid Psychiatric Disorders with Bipolar Disorder. Noro Psikiyatr Ars. 2021 Sep 20;58 (Suppl 1): S41-S46.

Featuring

Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

More

Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”

Michael Aldape, PhD
Senior Medical Science Liaison

Speaker Joseph F Goldberg, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Michael Aldape, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting: An Introduction To The Agitation In Alzheimer’s Screener For Caregivers (AASCTM)
2024-04-03 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
This webinar will describe how agitation associated with Alzheimer’s dementia (AAD) can manifest within the long-term care (LTC) setting and the burden that AAD can pose to both residents and caregivers. Presenters will discuss current approaches to recognizing and documenting AAD in the LTC setting, as well as potential challenges faced by nursing home caregivers. The Agitation in Alzheimer’s Screener for Caregivers (AASCTM) will be introduced as a potential tool for the identification and documentation of agitation in LTC residents with Alzheimer’s dementia.

Featuring

Manju Beier, PharmD, BCGP, FASCP
President & Founder, Geriatric Consultant Resources, LLC; Adjunct Associate Professor of Pharmacy at the University of Michigan

More

Dr. Manju T. Beier is President and founder of Geriatric Consultant Resources LLC, a firm established in 1995 to
provide clinical expertise in the field of geriatric pharmacotherapy and clinical pharmacology to geriatrics
professional organizations and health care plans. She has extensive experience targeting complex polypharmacy
issues and addressing medication management in older adults.

Previously, Dr. Beier was Chief Scientific Officer for a molecular diagnostics company based out of Renton, WA.
This position recognized her success as one of the pioneers in the profession of pharmacy for
pharmacogenomics research and education.

She holds an academic appointment as Adjunct Clinical Associate Professor of Pharmacy at the University of
Michigan, Ann Arbor, Michigan since 2000. She is currently a Board-Certified Geriatric Pharmacist (BCGP) until
2028.

Dr. Beier has been serving on the national Epocrates Senior Clinical Board since 2011 as the only pharmacist with
expertise in geriatrics. Her combined expertise in geriatrics, drug-drug and drug-gene interactions make her
uniquely qualified in the domains of personalized medicine, pharmacogenomics, and mitigating polypharmacy.

Dr. Beier received her B.S. Pharmacy and Doctor of Pharmacy degrees from the University of Utah in Salt Lake
City, Utah. She also holds a B.S. degree in Foods and Nutrition from Lady Irwin College, New Delhi, India.

Dr. Beier has given numerous seminars and workshops spanning the last 30 years addressing geriatric
pharmacotherapy, particularly psychopharmacology, pain management, Alzheimer’s Disease, cardiovascular
therapeutics, and the unique medication-related problems of older adults on a local, state, national, and
international level. She has also served on national P&T Committees as an independent member and reviewer.

Dr. Beier is widely published in peer-reviewed journals. She currently serves on the editorial advisory board of
several journals related to geriatrics and aging including Journal of the American Medical Directors Association
(JAMDA), and The Senior Care Pharmacist.

Dr. Beier is actively involved with the American Society of Consultant Pharmacists (ASCP) including serving two
terms on the Board of Directors. She recently completed her tenure as chair of Deprescribing Task Force for
ASCP (2018-2022) and was the chair/lead developer of Choosing Wisely Statements published online May 2021
and June 2022.

Dr. Beier was elected chair of the ASCP Foundation 2018-2020. She also co-chaired the ASCP Field Guide to
Reduce Medication Burden During COVID-19.

She belongs to several other national professional associations including American Medical Directors
Association (AMDA), and College of Psychiatric and Neurologic Pharmacists (CPNP).

Dr. Beier served as an expert panel national member for the 2003 Beers Criteria for Potentially Inappropriate
Drugs in the Elderly.

She is the recipient of several national pharmacy awards including being the 2006 recipient of the prestigious
George F. Archambault Award conferred by ASCP which is the Society’s highest honor. In 2012, she received the
Richard S. Berman Service Award for outstanding service and dedication to ASCP.

In November 2020, she was recognized as the recipient of the Women’s Spotlight Award by ASCP that recognizes
a female pharmacist for her outstanding contributions to senior care pharmacy and the mission of ASCP.

Jennifer Simmoneau, PhD (OPDC)
Senior Long-Term Care Medical Science Liaison, Medical Affairs

Speaker Manju Beier is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Jennifer Simmoneau, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Exploring Post-Traumatic Stress Disorder: Treatment Landscape and Unmet Needs Part 2
2024-04-10 12:00 - 12:30
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Current evidence-based guidelines for the diagnosis and treatment of post-traumatic stress disorder (PTSD) are valuable resources and can be used to help develop individual treatment plans for patients. This webinar will examine the current PTSD treatment landscape, including discussions on both psychotherapy and pharmacotherapy. In addition, presenters will review limitations and key considerations in the treatment of PTSD.

Featuring

David Block, MD, MMM, FAPA
Clinical Assistant Professor of Psychiatry, Western University of Health Sciences, Loma Linda University and California University of Health and Medicine; Private Practitioner, Costa Mesa, CA

More

Dr. David Block, a psychiatrist in Orange County, CA, is dual board-certified in psychiatry and addiction medicine and was elected to become a Fellow of the American Psychiatric Association in January 2014. Currently, he is the Clinical Assistant Professor of Psychiatry at the Western University of Health Sciences, Loma Linda University and California University of Health and Medicine, and is a Private Practitioner in Costa Mesa, CA.

Dr. Block has worked extensively in college mental health, managed health care, and community treatment settings with severely and persistently mentally ill individuals. He has extensive clinical experience working with individuals with PTSD, from both his public and private sector work, Additionally, he has written several articles in the psychiatric literature and taught seminars and lectures to students training in the mental health professions.

Madeline Shurtleff, PharmD
Managed Market Liaison

More

Dr. Shurtleff is a clinical pharmacist with experience in managed care and retail pharmacy. She has extensive knowledge in Medicaid and Medicare pharmacy operations and regulatory requirements. Dr. Shurtleff received her Doctor of Pharmacy (PharmD), Business Minor, and Leadership Minor from the University of Rhode Island. She is a licensed pharmacist in Illinois and Arizona.

Speaker David Block, MD, MMM, FAPA is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Madeline Shurtleff is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Exploring Post-Traumatic Stress Disorder: Pathophysiology
2024-05-16 12:00 - 12:30
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Although there may be many etiologies, Post-Traumatic Stress Disorder (PTSD) is a dynamic disorder that involves fluctuations between contrasting forms of emotional dysregulation.1 This webinar will provide a high-level overview of the pathophysiology of PTSD, including discussion of the potential role of monoamine neurotransmitter systems involved in emotional regulation and fear response in the amygdala.

References:
1. Yehuda R, et al. Nat Rev Dis Primers. 2015;1:15057.

Featuring

Steven Stoner, PharmD
Associate Dean for Student Affairs/Clinical Professor, University of Missouri-Kansas City School of Pharmacy

More

Steven Stoner, PharmD, BCPP, is Board Certified in Psychiatric Pharmacy. He is the associate dean of Student Affairs and a Clinical Professor at the UMKC School of Pharmacy. He received his PharmD from the University of Nebraska College of Pharmacy. Dr. Stoner completed a postdoctoral residency in psychiatric pharmacy practice and administration and a fellowship at Western Missouri Mental Health Center in Kansas City, Missouri.

Miranda Fisher, PhD
Medical Science Liaison

Speaker Steven Stoner, PharmD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Miranda Fisher, Phd. is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Combating Self-Stigma In Persons With Serious Mental Illness (SMI) With Narrative Enhancement & Cognitive Therapy (NECT)
2024-05-22 12:00 - 12:30
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Self-stigma refers to the negative attitudes, including internalized shame, that people with mental illness have about their condition.1 Many interventions are available to address self-stigma in the serious mental illness (SMI) population, and one of them is Narrative Enhancement and Cognitive Therapy (NECT). NECT is a manualized group-based psychosocial intervention that is directed towards helping people who have been labeled with a psychiatric diagnosis recover their sense of value and decrease internalized/self-stigma.2
Come and join us for this webinar, moderated by Sara Spencer, PharmD, MS, BCGP and featuring NECT founder, Philip Yanos, Ph.D., who will share the impact of internalized stigma on SMI individuals as well as the NECT methodology and provide a practical case vignette for implementation and application of this innovative therapy intervention into clinical practice.
Reference:

Stigma, Prejudice, and Discrimination Against People with Mental Illness. American Psychiatric Association. Psychiatry.org – Stigma, Prejudice, and Discrimination Against People with Mental Illness. Accessed: March 2024.
Narrative Enhancement and Cognitive Therapy. NECT Global. NECT Global

Featuring

Philip T. Yanos, PhD
Professor, Department of Psychology, John Jay College of Criminal Justice, City University of New York

More

Philip is a professor in the Psychology Department at John Jay College and The Graduate Center. A clinical psychologist, he received his Ph.D. in from St. John’s University in 1999 and completed a post-doctoral fellowship in mental health services research at Rutgers University in 2001, and has been faculty at John Jay since 2006. He is an internationally recognized expert in mental health stigma, author of the book “Written-Off: Mental Health Stigma and the Loss of Human Potential” (Cambridge University Press, 2018), associate editor of the journal “Stigma and Health,” and the author of over 130 peer-reviewed publications. He has been awarded the John Jay College Scholarly Excellence Award 5 times since 2009.

Sara A. Spencer, PharmD, MS, BCGP
Medical Science Liaison

Speaker Sara Spencer, PharmD, MS, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Home

Events

Webinar

Ask A Digital Navigator: Adopting Technology To Improve Mental Health
2024-06-20 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
As digital mental health tools are becoming an integral part of our healthcare landscape, there is a need to integrate them in our clinical practice. Dr. Maria Perez will facilitate this discussion about the role of digital navigators. Our experts, Noy Alon and Sarah Perret, will present on the challenges of implementing digital mental health tools into clinical practice, define the role of the digital navigator, and discuss the role of digital navigators in the implementation of technology into health care.

Featuring

Noy Alon, BS
Medical Student, Icahn School of Medicine at Mount Sinai, New York, NY

More

Noy Alon, BS was formerly the digital literacy director at the Digital Psychiatry Lab, Beth Israel Deaconess Medical Center, and led the team’s digital literacy curriculum development and community outreach. She also worked on app evaluation and was in charge of updating the largest database of mental health applications, known as the M-health Index and Navigation Database (MIND). Noy helped co-lead several digital navigator trainings and has trained over 100 behavioral health clinicians, volunteers, and community members in implementing digital health solutions.

Sarah Perret, MS, BS
Associate Editor, npj Women’s Health, Boston, MA

More

Sarah Perret served as the digital education director at the Digital Psychiatry Lab, Beth Israel Deaconess Medical Center, and led the team’s digital navigator training. She also worked on app evaluation and with perinatal women in the digital clinic.

Maria Perez, PharmD, AAHIVP
Medical Science Liaison – Digital Therapeutics

Speakers Noy Alon, BS and Sarah Perret, MS, BS are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Maria Perez, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Webinar Pre-Polling

Please fill out this survey before the webinar!

Pre polling survey for 6/20 webinar

How familiar are you with a Digital Navigator?

Not at all familiar

Slightly familiar

Moderately familiar

Extremely familiar
How often do you incorporate Digital Mental Health Tools in your practice?

Not at all

Infrequently

Sometimes

Most of the time

Always

Δ

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Practical Application Of Wellness Strategies For Individuals In Underserved Communities With Major Depressive Disorder (MDD) & Post-Traumatic Stress Disorder (PTSD)
2024-07-11 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Approximately 50 million United States adults are living with a mental illness, with 21 million having depression and 13 million with post-traumatic stress disorder.1-4 Minority individuals are among these prevalence statistics but are less likely to receive mental health care.5 In commemorating National Minority Mental Health Month, join us on this webinar moderated by Miranda Fisher, PhD and featuring Ifeanyi M. Olele, DO, MBA, MS, where they will discuss the prevalence and impact of mental illness within the underserved communities, address the clinical presentation of MDD & PTSD present in this population, and share practical wellness approaches to integrate and support the recovery journey for these individuals.

References:

Mental Health of America. Quick Facts and Statistics About Mental Health. Quick Facts and Statistics About Mental Health | Mental Health America (mhanational.org). Accessed May 2024
Lehavot K et al. Am J Pre Med. 2018;54(1), e1-e9.
US Census Bureau. (2022). National Population by Characteristics: 2020-2022. Retrieved from https://www.census.gov/data/tables/time-series/demo/popest/2020s-national-detail.html. (Data on file).
U.S. Department of Veterans Affairs (VA). How Common is PTSD in Adults? How Common is PTSD in Adults? – PTSD: National Center for PTSD (va.gov) . Accessed May 2024
Depression and Bipolar Support Alliance. Statistics About Disparities in Mental Health Care. Statistics About Disparities in Mental Health Care – Depression and Bipolar Support Alliance (dbsalliance.org). Accessed May 2024

Featuring

Ifeanyi Olele, DO, MBA, MS
Psychiatrist & CEO at Genesis Psychiatric Solutions, Washington DC & Genesis TMS and Wellness, Fairfax VA

More

Ifeanyi M. Olele is a psychiatrist & CEO of Genesis Psychiatric Solutions in Washington D.C. He is a Board-Certified psychiatrist and completed his undergraduate studies in Psychobiology at the University of California Los-Angeles (UCLA). Dr. Olele received a medical degree from Philadelphia College of Osteopathic Medicine (PCOM) along with an MBA in Health Services Administration from St. Joseph’s University in Philadelphia. He also earned a Master of Science degree in Medical Science from Hampton University in Hampton, Virginia. Upon completion of medical school, Dr. Olele completed his psychiatry residency and served as Chief Resident in Larkin Community Hospital in Miami, Florida. Dr. Olele received training on maternal mental health at the Seleni Institute and cognitive behavior therapy at the Beck Institute.

Miranda Fisher, PhD
Medical Science Liaison

Speaker Ifeanyi Olele, DO, MBA, MS is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Miranda Fisher, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Pseudobulbar Affect (PBA) In Patients With Traumatic Brain Injury (TBI)
2024-07-17 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Join us as Michelle Lavagnino and Dr. Heidi Fusco discuss an overview of Pseudobulbar Affect (PBA) in Traumatic Brain Injury (TBI) patients. This webinar will discuss the prevalence and burden of TBI patients suffering from PBA and the importance of diagnosing in several different practice settings.

Featuring

Heidi Fusco, PM&R
Assistant Professor, Department of Rehabilitation Medicine at NYU Grossman School of Medicine; Medical Director, Brain Injury Unit, Queens Nassau Nursing and Rehabilitation; Assistant Director, Traumatic Brain Injury Program

Michelle Lavagnino, DrPH(c)
Medical Science Liaison, Long-term Care

Dr. Heidi Fusco is a paid consultant of Otsuka Pharmaceutical Development & Commercialization. (OPDC)Michelle Lavagnino is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Improving Quality Of Life, Functioning & Well-being In Individuals Living With Bipolar Disorder
2024-07-25 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Bipolar disorder is a lifelong, chronic mental health disorder characterized by extreme shifts in mood that can have a profound negative effect on daily functioning, cognition, and quality of life for individuals living with the disorder.1 During this webinar, guest speaker Dr. Martha Sajatovic, and Medical Science Liaison, Taylor Ochalek, will address why quality of life may be compromised in individuals with bipolar disorder and review the utility of measurement-based tools. Dr. Sajatovic will then discuss potential advantages of implementing both pharmacological and psychosocial interventions to improve quality of life, functioning and well-being.

References:
1. Bonnín CDM, et al. Improving Functioning, Quality of Life, and Well-being in Patients with Bipolar Disorder. Int J Neuropsychopharmacol. 2019 Aug 1;22(8):467-477.

Featuring

Martha Sajatovic, MD
Psychiatrist, Director Neurological and Behavioral Outcomes Center, University Hospital Cleveland Medical Center and Professor, Case Western Reserve University School of Medicine

More

Martha Sajatovic, MD holds the Willard Brown Chair in Neurological Outcomes at University Hospitals Cleveland Medical Center (UH CMC) and the Rocco L. Motto Professorship in Child & Adolescent Psychiatry. Dr. Sajatovic directs the Neurological and Behavioral Outcomes Center at UHCMC/Case Western Reserve University. She has subspecialty certification in Behavioral Neurology & Neuropsychiatry. Dr. Sajatovic is a Professor of Psychiatry and Neurology at Case Western Reserve University School of Medicine (CWRU) in Cleveland, Ohio. Dr. Sajatovic is a researcher, educator, and clinician who has devoted herself to studying and treating traditionally, hard-to-treat populations with central nervous system disorders. Dr. Sajatovic’s research interests have focused on neuropsychiatric outcomes of brain disorders across the life-span, including epilepsy, stroke, Alzheimer’s disease, and other types of dementia and Parkinson’s disease. She has authored or co-authored over 250 peer-reviewed publications and has published over 40 book chapters or books on neuropsychiatric topics. Dr. Sajatovic has been a recipient of the Exemplary Psychiatrist Award bestowed by the National Alliance for the Mentally Ill (NAMI), was a Depression and Bipolar Support Alliance (DBSA) Gerald Klerman Investigator Award winner in 2006 and 2016, and in 2018 received the Rebecca Goldberg Kaufman American Epilepsy Society (AES) Clinical Award in Ethical Neuropsychiatry.

Taylor Ochalek, PhD
Medical Science Liaison

Speaker Martha Sajatovic, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Taylor Ochalek is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

The Agitation In Alzheimer’s Screener For Caregivers (AASC™): How Caregivers Can Use This New Screener To Recognize The Breadth Of Agitation Symptoms & Facilitate Conversations With Healthcare Professionals
2024-08-01 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
As a follow-up to the previous webinar, “An Introduction to the AASCTM,” this webinar will re-ground on the current landscape of Alzheimer’s dementia (AD) and the negative impact agitation in Alzheimer’s dementia (AAD) has on both caregivers and patients. Additionally, it will introduce guidance on how caregivers should use the AASCTM to support patients. During this session, presenters will provide a didactic overview and engage in role-playing scenarios to illustrate how community caregivers can use the AASCTM to facilitate a conversation with their health care provider (HCP).

Featuring

Marc E. Agronin, MD
Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine

Carrie Shaw, MD
CEO & Founder of Embodied Labs

Katie Sulkowski, PharmD
Medical Science Liaison

Speakers Dr. Marc E. Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Katie Sulkowski, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Psychotherapeutic Approaches in PTSD Treatment
2024-08-22 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder

Clinical guidelines recommend both pharmacologic and non-pharmacological interventions in the treatment of post-traumatic stress disorder (PTSD)1. This presentation will highlight these interventions in addition to exploring the benefits of combined pharmacological and non-pharmacologic treatments. Objectives for this webinar include: a review of PTSD diagnostic criteria; common psychotherapies utilized in PTSD; a discussion of the challenges associated with engaging patients in psychotherapy; and the benefits of combined pharmacologic and non-pharmacologic treatments.

Join us for an informative webinar moderated by Haneefa Rakeeb DNP, PMHNP-BC, RN alongside esteemed speaker Christiian Storm Credle, PsyD.

References:

U.S. Department of Veterans Affairs. 2023. www.healthquality.va.gov/guidelines/MH/ptsd/VA-DoD-CPG-PTSD-Full-CPG.pdf

Featured Speakers

Christiian Storm Credle, PsyD (he/him/his)
Director of Behavioral Health at Mazzoni Medical Center in Philadelphia, PA

Haneefa Rakeeb, DNP, PMHNP-BC, AFN-BC
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

More

Haneefa has been a nurse for over 10 years and is a certified psychiatric mental nurse practitioner. She is board certified as an advanced forensic nurse through the ANCC and is specialized as a sexual assault nurse examiner since 2013. She earned her doctorate degree in nursing practice in 2021 from Wilkes University, with a focus on the relationship between PTSD and sexual assault patients.

Christiian Storm Credle, PsyD, is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Haneefa Rakeeb, DNP, PMHNP-BC, RN is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
June 2024 US.CORP.X.24.00197

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Clinical Perspectives on the Impact of Agitation in Alzheimer’s Dementia Among the Hispanic Community
2024-09-18 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder

Latinos/Hispanics represent the fastest-growing population in the United States yet, they face significant health disparities in Alzheimer’s Dementia (AD) diagnosis and care.1 Join us for an enlightening discussion moderated by John Awad, MD, alongside esteemed speakers Freddi Segal-Gidan, PA, PhD (Keck School of Medicine of University of Southern California) and Daniel Jimenez, PhD (University of Miami), as they share their clinical perspectives on the impact of AD among the Hispanic population, analyze the risk factors and clinical outcomes challenges that the patients and caregivers may face, discuss the profound effect of agitation in Alzheimer’s Dementia (AAD) within this population and explore the roles of the medical community in addressing symptoms of agitation.

References:

Alzheimer’s Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health. Irving E. Vega et al. J Alzheimers Dis. 2017; 58(4): 979–992.

Featured Speakers

Freddi Segal-Gidan, PA, PhD
Director of the USC-Rancho California Alzheimer's Disease Center – LA County Department of Health. Associate Professor of Clinical Neurology and Family Medicine – Keck School of Medicine, University of South California

Daniel Jimenez, PhD
Associate Professor in the Department of Psychiatry and Behavioral Sciences – Univ. of Miami Miller School of Medicine. President-Elect of the American Society of Hispanic Psychiatry

John Awad, MD (OPDC)
Senior Medical Science Liaison

Freddi Segal-Gidan, PA PhD is a volunteer and has declined payment for this activity.

Daniel Jimenez, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

John Awad, MD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
June 2024 US.CORP.X.24.00182

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

The Danger of Post-Traumatic Stress Disorder (PTSD) Stigma Among Marginalized Communities
2024-10-10 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Marginalized communities are those excluded from mainstream social, economic, educational, and/or cultural life. Examples include race, age, sexual orientation, gender identity, physical ability, language and/or immigration status1. This webinar aims to raise awareness between post-traumatic stress disorder (PTSD) and the stigma associated with marginalized communities. A review of risk factors, challenges in identification, diagnosis, and treatment of PTSD in this community will be explored; followed by a discussion of barriers to accessing care and how healthcare professionals can improve these challenges in practice. Join us for an informative webinar moderated by Haneefa Rakeeb DNP, PMHNP-BC, RN alongside esteemed speakers Christiian Storm Credle, PsyD and Christopher Thomas Tobias, MS, MHA, CHFP, PA-C.

References:
1. Sevelius, J. M., et al. (2020). Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic. AIDS and behavior, 24(7), 2009–2012. https://doi.org/10.1007/s10461-020-02920-3

Featured Speakers

Christiian Storm Credle, PsyD (he/him/his)
Director of Behavioral Health at Mazzoni Medical Center in Philadelphia, PA

Christopher Thomas Tobias, MS, MHA, CHFP, PA-C (he/him/his)
Director of Academic Education & Clinical Assistant Professor for Physician Studies at the School of Health Professions; Saint Joseph’s University, Philadelphia, PA

Haneefa Rakeeb, DNP, PMHNP-BC, AFN-BC
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

More

Haneefa has been a nurse for over 10 years and is a certified psychiatric mental nurse practitioner. She is board certified as an advanced forensic nurse through the ANCC and is specialized as a sexual assault nurse examiner since 2013. She earned her doctorate degree in nursing practice in 2021 from Wilkes University, with a focus on the relationship between PTSD and sexual assault patients.

Disclaimers

Speakers Christtian Storm Credle, PsyD and Christopher Thomas Tobias, MS, MHA, CHFP, PA-C, are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Haneefa Rakeeb, DNP, PMHNP-BC, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.March 2024 US.CORP.X.24.00068

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Factors in Designing and Evaluating Clinical Trials for App-Based Interventions
2024-10-14 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
As digital mental health interventions are becoming an integral part of our healthcare landscape, there is a need to better understand digital clinical trials and how to evaluate their outcomes to support clinical decision making. In this webinar, Dr. Sara Morimoto, PsyD will share her expertise in developing and testing app-based mental health interventions. In this context, she will discuss design aspects and other factors that may require special consideration when evaluating clinical outcomes for app-based treatments.

Objectives:

Review the requirements for FDA Clearance of Prescription Digital Therapeutics (PDT)
Review considerations in the evaluation of clinical trials for digital therapeutics (DTx)
Discuss the importance of clinically meaningful data in the development and assessment of DTx and impact on patient care.

Featuring

Sarah S. Morimoto, PsyD
Associate Professor – Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, UT

More

Sarah Shizuko Morimoto, PsyD, is Associate Professor, Population Health Sciences, Division of Health Systems Innovation and Research, as well as Director of the Neurotherapeutics Lab and Director of Cognitive Remediation in Psychiatry at the University of Utah School of Medicine in Salt Lake City. Dr Morimoto’s research encompasses the full range of digital cognitive remediation intervention development, from identifying targeted and clinically relevant cognitive deficits to developing computerized paradigms and conducting clinical trials. Dr Morimoto received her PsyD in clinical psychology from the PGSP-Stanford PsyD Consortium through Palo Alto University and Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, California. She completed a clinical internship at Beth Israel Deaconess/Massachusetts Mental Health Center/Harvard Medical School Department of Psychiatry, Boston, Massachusetts, a fellowship in clinical neuropsychiatry at New York-Presbyterian/Weill Cornell Medical Center, and a fellowship in geriatric mood disorders at Weill Cornell Institute of Geriatric Psychiatry at Weill Cornell Medical College.

Scott Schepers, PhD
Medical Science Liaison

Sara Morimoto is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Scott Schepers is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
August 2024 US.CORP.X.24.00250

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Addressing Caregiver Burden and Identifying Agitation in Alzheimer’s Dementia
2024-11-13 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Over 11 million Americans provide unpaid care for people with Alzheimer’s or other dementia.1 The majority (80%) of people with Alzheimer’s disease and related dementia are receiving care in their home.2 The demand for caregivers and the burden can negatively impact their quality of life and ability to provide care. Come and join us for this webinar, as our speaker and moderator highlight the impact of caregiver burden, discuss challenges in recognizing agitation in Alzheimer’s dementia, and share tools that caregivers can utilize in identifying and managing this condition.

References:

Alzheimer’s Association. Facts and figures infographic. alzheimers-facts-and-figures-infographic.pdf. Accessed: September 2024.
Center for Disease Control and Prevention (CDC). Caregiving for a Person with Alzheimer’s Disease or a Related Dementia. Caregiving for Person with Alzheimer’s Disease or a related Dementia | Alzheimer’s Disease and Healthy Aging | CDC. Accessed: September 2024

Featuring

E. Jeffrey Greenberg, MD
Neurologist at Princeton & Rutgers Neurology, P.A., Co-Founder of Advanced Clinical Institute

More

Dr. Jeffrey Greenberg, a native of Philadelphia, joined Princeton & Rutgers Neurology in 2003. He received his Bachelor’s degree in English from Cornell University and his medical degree from Drexel University, College of Medicine. He completed his Neurology residency at the Albert Einstein College of Medicine in New York, serving as Chief Resident in his final year. He subsequently completed an EMG/Neuromuscular fellowship at Albert Einstein. He is Board Certified in Neurology by the American Board of Psychiatry and Neurology and also Board Certified by the American Associate of Neuromuscular and Electrodiagnostic Medicine.

Dr. Greenberg now focuses his practice on Parkinson’s Disease, Dementia, Multiple Sclerosis, and Neuromuscular Disease. Additionally, he has experience as a Principle Investigator for Alzheimer’s disease clinical trials and remains involved in the field.

Lindsey Wright, PharmD
Medical Science Liaison

E. Jeffrey Greenberg, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Lindsey Wright, PharmD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
September 2024 US.CORP.X.24.00271

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Treatment Pathways Across Cultures
2024-11-14 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Understanding the cultural aspects of treating bipolar disease offers invaluable insights into how diverse ethnic backgrounds influence the perception, diagnosis and the management of this condition. Appreciating these differences can improve communication between healthcare providers and patients and lead to more improved, personalized and effective healthcare treatment plans. During this webinar, Sr. MSL Dr. Michael Aldape will be talking with Dr. Crystal Clark and Dr. Mauricio Tohen as they guide us on a lively discussion addressing the impact of culture across treatment pathways for bipolar disorder, and how cultural context can be integrated into treatment strategies for this condition.

Featuring

Michael Aldape, PhD
Senior Medical Science Liaison

Crystal T. Clark, MD, MSc
Associate Professor, Department of Psychiatry, University of Toronto; Research Investigator, Associate Head of Research, Department of Psychiatry, Women’s College Hospital (Toronto, Ontario)

More

Dr. Clark is an Associate Professor in the Department of Psychiatry at the University of Toronto. She is also a scientist at Women’s College Research Institute and will serve as the Associate Head of Research at the Women’s College Hospital. Dr. Clark is a past president of the Marcé of North America and serves on the board of directors of Marcé International. She received her Bachelor of Arts in Psychology from Northwestern University and her Master of Science and Medical Doctorate from the University of Louisville, Kentucky (2006). She completed her adult psychiatry training and served as chief resident at Johns Hopkins in Baltimore, Maryland, USA (2010). Prior to completing her MSc in Clinical Investigation Sciences (2012), she completed fellowship training in clinical research and reproductive psychiatry while also serving on faculty at the Baylor College of Medicine/Michael E. Debakey VA as well as the University of Pittsburgh Medical Center/ Pittsburgh VA Healthcare Systems. Prior to joining UofT, she served as an Associate Professor at Northwestern University, Chicago. There she was a Staff Psychiatrist at the Northwestern Memorial Hospital; and Clinical Director of the Women’s Outpatient Program, Asher Center for the Study and Treatment of Depressive Disorders. She also co-founded and co-directed and advanced training fellowship in women’s and reproductive mental health.

Mauricio Tohen, MD, DrPH, MBA
Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico

More

Mauricio Tohen, MD, DrPH, MBA, is a University Distinguished Professor and Chairman of the Department of Psychiatry at the University of New Mexico Health Science Center, Albuquerque NM. From 2009 to 2013 he was a Professor of Psychiatry and The Krus Endowed Chair in Psychiatry at the University of Texas Health Science Center at San Antonio. Dr. Tohen received his medical degree from the National University of Mexico and his Doctor of Public Health degree in Epidemiology from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, a clinical fellowship at McLean Hospital and Harvard Medical School, and a teaching fellowship in Epidemiology at the Harvard School of Public Health. From 1988 to 1997, Dr. Tohen was the Clinical Director of the Bipolar and Psychotic Disorders Program at McLean Hospital. From 1997 to 2008 he was a member of Lilly Research Laboratories reaching the senior-most scientific level of Distinguished Lilly Scholar. In 2009 he joined the University of Texas Health Science Center at San Antonio as the Head of the Division of Mood and Anxiety Disorders. Dr. Tohen received a National Service Award in Psychiatric Epidemiology from the National Institute of Mental Health (NIMH) and Harvard University. He also received a FIRST award from the NIMH, the Pope Award from McLean Hospital, and a NARSAD Young Investigator Award and the Simon Bolivar Award from the American Psychiatric Association. In 2014 he was named by Thomson Reuter’s “The World’s Most Influential Scientific Minds, 2014”. Honorees were the scientists who ranked in the Top 1 percent by citations of their published work in 21 broad fields between 2002 and 2012.

Dr. Michael Aldape, PhD, Dr. Mauricio Tohen, MD, DrPH, MBA and Dr. Crystal Clark, MD, MSc are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
September 2024 US.CORP.X.24.00280

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Post-Traumatic Stress Disorder (PTSD): Clinical Considerations and Unmet Needs
2024-11-15 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
During an expert interview, Otsuka Sr. Medical Science Liaison (MSL), Mark Tacelosky will be talking with Dr. Christine Costa who will discuss a variety of topics related to the management of patients with PTSD. The conversation will include the definition of PTSD, incidence/prevalence, trauma types, challenges in diagnosis, treatment, and clinical barriers.

Featuring

Christine Costa, Ph.D., DNP, RN, PMHNP-BC
Psychiatric nurse practitioner, Gateways Hospital and Mental Health Center; Associate Professor at California State University, Long Beach School of Nursing

More

Dr. Costa is a psychiatric nurse practitioner with over 20 years of experience in the health field, currently working for Gateways Hospital and Mental Health Center. She serves as an Associate Professor at California State University, Long Beach School of Nursing. Costa received her Doctor of Philosophy from William Carey University in Hattiesburg, Mississippi, and a Doctor of Nursing Practice from Brandman University in Irvine, California.

Mark Tacelosky, PharmD
Senior Medical Science Liaison

Christine Costa is a paid consultant] of Otsuka Pharmaceutical Development & Commercialization, Inc.

Mark Tacelosky is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
October 2024 US.CORP.X.24.00294

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Monoamine Neurotransmitter Dysregulation in Major Depressive Disorder
2024-12-17 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Join us for a PsychU webinar with Drs. W. Clay Jackson and Christian Aurup as they discuss the potential relationship between the monoamine neurotransmitter systems in Major Depressive Disorder (MDD). Our webinar aims to provide valuable insights into the relationship between the monoamine neurotransmitter systems and the overlapping projections throughout the brain, identify monoamine neurobiological pathways and their potential role in psychiatric symptoms, and discuss neurobiological theories in relation to treatment options for MDD.

Featuring

William Clay Jackson, MD, DipTh
Assistant Professor of Clinical Psychiatry & Family Medicine; University of TN College of Medicine

Christian Aurup, PhD
Medical Science Liaison

W. Clay Jackson is a paid consultant and Christian Aurup is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
October 2024 US.CORP.X.24.00314

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Identification of Agitation in Patients with Dementia due to Alzheimer’s Disease: Perspectives from the Primary Care Provider
2024-12-18 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Join us for a discussion with Dr. C. Brendan Montano, as he shares his perspective from the primary care setting on identifying and responding to agitation associated with dementia due to Alzheimer’s disease. The discussion will explore the prevalence and burden of agitation in Alzheimer’s dementia, recognition of agitation symptoms, as well as the use of the AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders. This tool is designed to assist caregivers in recognizing AAD and starting the conversation with their medical provider.

Featuring

C. Brendan Montano, MD, PC
Director and Principal Investigator for Connecticut Clinical Research in Cromwell, Connecticut

More

Brendan Montano, MD, is the owner and medical director of Montano Wellness, LLC, and director of and a principal investigator for CT Clinical Research, all in Cromwell, Connecticut. Dr Montano is also an attending physician at Middlesex Memorial Hospital in Middletown, Connecticut, a clinical instructor at Springfield College in Springfield, Massachusetts, and a primary care section advisor online for PsychU. He earned his medical degree from Albany College in Albany, New York. He completed his residency in internal medicine at Saint Francis Hospital and Medical Center in Hartford, Connecticut. Dr Montano has served as a principal investigator for over 120 clinical trials to evaluate the safety and efficacy of novel therapeutics for indications such as attention-deficit/hyperactivity disorder, major depressive disorder, and many other psychiatric and neurologic conditions. He is an editorial board member of The Primary Care Companion for CNS Disorders.

Amaka Onyereri, PharmD, BCPS
Medical Science Liaison

More

Amaka Onyereri received her bachelor’s degree in general science and Doctor of Pharmacy degree from Oregon State University/Oregon Health Sciences University. Her passion for patient care led her to practice clinically as a community pharmacist where she served patients for close to 20 years in different capacities as a staff pharmacist, pharmacy manager and pharmacy clinical services manager.
As a Pharmacy Clinical Services Manager, Amaka spearheaded various clinical and patient care initiatives such as immunizations, medication therapy management, point of care testing, and most recently a long-acting injectables pilot for antipsychotics.

Lindsay Teliska, PhD
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

Dr. C. Brendan Montano is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Amaka Onyereri is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Lindsay Teliska is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
November 2024 US.CORP.X.24.00325

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Incorporating Digital Therapeutics into the Patient Journey
2025-01-13 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Join us for an insightful webinar exploring digital therapeutics (DTx) as innovative, nonpharmacologic treatment options for mental health conditions. Explore ways incorporating DTx into clinical practice, from identifying the appropriate patients to understanding potential benefits, limitations, outcomes, and accessibility options. Learn approaches for educating patients and caregivers and leveraging peer recommendations to increase familiarity with DTx. Dr. Pooja Raghani will facilitate this discussion, and our speakers, Drs. Arwen Podesta and Timothy Aungst, will share real-world stories to illustrate the transformative potential of DTx in improving patient care.

Featuring

Arwen Podesta, MD
Psychiatrist Owner/Director Podesta Wellness, New Orleans, LA

More

Arwen Podesta, MD, is a New Orleans–based board-certified adult psychiatrist with sub-specializations in addiction medicine, forensic psychiatry, and integrative medicine. After Hurricane Katrina, Dr. Podesta became involved in actioning psychiatric care for underserved and disenfranchised populations and was awarded the Gambit’s 40 Under 40 in 2009. Since then, she has worked in the public sector as Medical Director of multiple addiction treatment centers and as a consultant for the Orleans Criminal Court, Drug Court, and Re-entry Services. Additionally, she serves as a consulting Addiction Medicine Specialist. Dr. Podesta’s primary focus is access to integrative mental health and addiction treatment as well as rational prescribing practices. She is President of the Louisiana Psychiatric Medical Association and serves on the Opioid Abatement Task Force for the State of Louisiana. She is a distinguished fellow of both the American Psychiatric Association and the American Society of Addiction Medicine. A renowned speaker, Dr Podesta regularly travels to teach and speak on the topics of addiction medicine and integrative psychiatry.

Timothy Aungst, PharmD
Section Advisor, Professor of Pharmacy Practice – Massachusetts College of Pharmacy and Health Sciences

More

Timothy D. Aungst, PharmD, is Professor of Pharmacy Practice at MCPHS and a clinical pharmacist. For the past decade, Dr Aungst has focused upon the role of technology within clinical care. This has included the evaluation of mobile medical applications and constructing frameworks to identify clinically relevant mobile health tools. He has evaluated 2000+ mobile apps and related digital health products and has served as a mentor and judge for the MIT hacking medicine program and other innovative groups. By combining his clinical knowledge with his digital health knowledge, he has become a leading subject matter expert on integrating smart medications, digital therapeutics, digital medicines, and remote patient monitoring, and digitalizing patient care. He is an advisor for the Digital Therapeutics Alliance and part of a focus group for the Digital Medicine Society. Dr Aungst has worked with the American Pharmacist Association and the American Association of Colleges of Pharmacy to create standards of digital health care for current and future learners and certificates and training modules to help prepare the pharmacy profession for the era of digital health care.

Pooja S Raghani, PsyD, MBI
Medical Science Liaison

Arwen Podesta, MD and Timothy D. Aungst, PharmD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

Pooja Raghani, PsyD, MBI is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
December 2024 US.CORP.X.24.00341

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Understanding Caregivers’ Perspectives: Agitation in Alzheimer’s Dementia
2025-03-26 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Agitation in Alzheimer’s Dementia is frequently under-recognized by caregivers and under-diagnosed by healthcare professionals (HCPs) despite its prevalence.1-3 Caregivers are essential in recognizing, assessing, and communicating these symptoms to HCPs. Join us as we explore the caregivers’ insights on the “most bothersome” symptoms and what they view as meaningful improvements or worsening in agitation. We will delve into practical strategies, using the Agitation in Alzheimer’s Screener (AASC®) to help identify symptoms and facilitate conversations with HCPs.

References:

Halpern R, et al. Int J Geriatr Psychiatry. 2019;34(3):420-431.
Lanctot KL, et al. Alzheimers Dement (NY). 2017;3(3):440-449.
Stella F, et al. Int J Geriatr Psychiatry. 2015;30(12):1230-1237.

Featuring

David E. Lewis, DO
Physician, Ann’s Choice, Inc.; Medical Director, Suncrest Care Hospice; Owner & Provider, Adult, Geriatric, Osteopathic (AGO) Medical Care, LLC.

More

Dr David E. Lewis is a Primary Care provider who is Board Certified in both Family Medicine and Geriatric Medicine. He was born and raised in Levittown, PA and earned his Bachelor of Arts in Biology from Arcadia University and a medical degree from Lake Erie College of Osteopathic Medicine (LECOM). Currently, Dr Lewis is a primary care physician at Bucks Family Medicine in Pennsylvania, a part-time medical director at Angelic Healthcare, and the owner and primary provider at Adult, Geriatric, Osteopathic (AGO) Medical Care, LLC. He is an active member of several professional-medical organizations, and when Dr. Lewis is not working and making home medical-visits, he enjoys playing his saxophones.

Moderators

Amaka Onyereri, PharmD, BCPS
Medical Science Liaison

More

Amaka Onyereri received her bachelor’s degree in general science and Doctor of Pharmacy degree from Oregon State University/Oregon Health Sciences University. Her passion for patient care led her to practice clinically as a community pharmacist where she served patients for close to 20 years in different capacities as a staff pharmacist, pharmacy manager and pharmacy clinical services manager.
As a Pharmacy Clinical Services Manager, Amaka spearheaded various clinical and patient care initiatives such as immunizations, medication therapy management, point of care testing, and most recently a long-acting injectables pilot for antipsychotics.

Chuck Dillay
Senior Medical Science Liaison, Medical Affairs

Dr. David E. Lewis is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Amaka Onyereri, PharmD, BCPS and Chuck Dillay are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
February 2025 US.CORP.X.25.00025

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Meet the New PsychU PTSD Section Advisor: Dr. James Murrough
2025-04-23 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
During an expert interview, Otsuka Sr. Medical Science Liaison (MSL), Mark Tacelosky, will be talking with the new PsychU Post Traumatic Stress Disorder (PTSD) Section Advisor Dr. James Murrough. The conversation will cover Dr. Murrough’s experience treating PTSD and include his thoughts on challenges, unmet needs, and the future of treatment.

Featuring

James Murrough, M.D., Ph.D.
Associate Professor of Psychiatry and Neuroscience, Director of the Depression & Anxiety Center for Discovery & Treatment, Icahn School of Medicine at Mount Sinai

More

James Murrough, M.D., Ph.D., is an Associate Professor of Psychiatry and Neuroscience, and the Director of the Depression & Anxiety Center for Discovery & Treatment at the Icahn School of Medicine at Mount Sinai. He conducts clinical and translational research aimed at understanding the biological basis of mood and anxiety disorders. Dr. Murrough received his medical degree from Tufts University School of Medicine and a doctoral degree from Mount Sinai.

James Murrough is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Mark Tacelosky is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
March 2025 US.CORP.X.25.00042

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Patient Treatment Preferences in Bipolar-I Disorder: Are We Really Listening?
2025-05-29 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Pharmacological treatment with oral or long acting injectable medications are recommended to reduce relapse risk and promote quality of life in patients with Bipolar-I Disorder. Healthcare providers and patients with Bipolar-I Disorder share many treatment goals, valuing treatment efficacy and stability and allowing patients to engage effectively within society and live life with a sense of normalcy. Addressing patient preferences in treatment planning and ensuring those align with treatment goals is essential in providing quality mental health care.

This on-demand webinar features Roger McIntyre, MD, FRCPC, and Kevin Williams, MS, MPAS, PA-C, who share their clinically-informed approaches to empower healthcare providers to engage in meaningful conversations with patients and translate patient preferences and goals into optimized treatment plans.

Featuring

Roger S. McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology, University of Toronto,
Head of the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada

More

Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada; Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada, Director as well as Co-Chair of the Scientific Advisory Board of the Depression and Bipolar Support Alliance (DBSA) from Chicago, Illinois; Professor and Nanshan Scholar at Guangzhou Medical University; Adjunct Professor at College of Medicine in Korea University; and Clinical Professor at State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA, and at Department of Psychiatry and Neurosciences University of California School of Medicine, Riverside, California, USA. Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.

Kevin Williams, MS, MPAS, PA-C
CEO, Lead Clinician, OnPoint Behavioral Health Inc.

More

Kevin Williams, MS, MPAS, PA-C received a master’s degree in Interdisciplinary Medical Sciences from the University of South Florida and master’s degree in Physician Assistant Studies from South University. He is the CEO and Lead Clinician of OnPoint Behavioral Health Inc. in the Tampa Bay area where he provides innovative, holistic, and compassionate care to patients of all ages and has over 6 years of experience treating patients across inpatient, outpatient, and long-term care settings.

Dr. Roger McIntyre, MD, FRCPC and Mr. Kevin Williams, MS, MPAS, PA-C are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
February 2023 US.CORP.X.24.00040

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Using a Narrative Approach Therapy in Addressing PTSD Self-Stigma
2025-06-04 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Join us for this on-demand webinar, moderated by Haneefa Rakeeb, DNP, PMHNP-BC, AFN-BC, Philip Yanos, Ph.D., and JoAnn Dorio Burton, CPRP, who share the impact of narrative therapy interventions to support individuals suffering from PTSD. We will briefly discuss the NECT methodology and delve into the impact of The Hero’s Journey in the recovery process.

Featuring

JoAnn Dorio Burton, CLC, CPRP
Author, Consultant, Trainer, Hero's Journey® Workshop/Class Facilitator,
Life Coach

More

JoAnn is a trainer, consultant and author. She has worked as the Community Programs Coordinator at Windhorse Community Services, in Boulder Colorado. JoAnn is a longtime advocate of community mental health, clubhouse programs, and psychiatric rehabilitation. She has a BA degree in Therapeutic Recreation and Sociology, (concentration Social Work) from Lehman College, CUNY and attended the Transpersonal Counseling Program at Naropa University. In 2018, JoAnn received the Psychiatric Rehabilitation Practitioner Award.

Philip T. Yanos, PhD
Professor, Department of Psychology, John Jay College of Criminal Justice, City University of New York

More

Philip is a professor in the Psychology Department at John Jay College and The Graduate Center. A clinical psychologist, he received his Ph.D. in from St. John’s University in 1999 and completed a post-doctoral fellowship in mental health services research at Rutgers University in 2001, and has been faculty at John Jay since 2006. He is an internationally recognized expert in mental health stigma, author of the book “Written-Off: Mental Health Stigma and the Loss of Human Potential” (Cambridge University Press, 2018), associate editor of the journal “Stigma and Health,” and the author of over 130 peer-reviewed publications. He has been awarded the John Jay College Scholarly Excellence Award 5 times since 2009.

Haneefa Rakeeb, DNP, PMHNP-BC, AFN-BC
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

More

Haneefa has been a nurse for over 10 years and is a certified psychiatric mental nurse practitioner. She is board certified as an advanced forensic nurse through the ANCC and is specialized as a sexual assault nurse examiner since 2013. She earned her doctorate degree in nursing practice in 2021 from Wilkes University, with a focus on the relationship between PTSD and sexual assault patients.

JoAnn Burton and Philip Yanos are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

Haneefa Rakeeb is a an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
February 2025 US.CORP.X.25.00024

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Identifying Challenges and Navigating Treatment Landscape for Management of Agitation Associated with Dementia Due to Alzheimer’s Disease
2025-07-30 12:00 - 13:00
Home

Events

Webinar

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Impact of Adherence on Patients with BP I Disorder
Join us for a discussion with Dr. Douglas McLaughlin, as he provides perspective on identifying challenges and navigating the treatment landscape for management of agitation associated with dementia due to Alzheimer’s disease. Both the community and long-term care settings will be explored during this time together.

Featuring

Doug McLaughlin, DO
Adult Psychiatrist, Cleveland Clinic

More

Dr. Douglas McLaughlin is a board-certified psychiatrist who practices at Cleveland Clinic in Cleveland, Ohio. Dr. McLaughlin sees patients in both the inpatient and outpatient setting. His expertise is in mood disorders, anxiety disorders, ADHD, schizophrenia and dementia. Dr. McLaughlin is also a Clinical Assistant Professor of Psychiatry at Ohio University College of Osteopathic Medicine.

Lindsay Teliska, PhD
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.

Craig Owens, RPh​
Long Term Care Medical Science Liaison

Douglas McLaughlin, DO, is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Lindsay Teliska, PhD & Craig Owens, RPh are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
June 2025 US.CORP.X.25.00116

Registration

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…
